IMMUNOCORE HOLDINGS PLC-ADR (IMCR) Forecast, Price Target & Analyst Ratings

NASDAQ:IMCR • US45258D1054

Current stock price

31.05 USD
-0.76 (-2.39%)
At close:
31.5 USD
+0.45 (+1.45%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMMUNOCORE HOLDINGS PLC-ADR (IMCR).

Forecast Snapshot

Consensus Price Target

Price Target
$68.07
+ 119.22% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
109.8M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.74%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$68.07
Upside
+ 119.22%
From current price of $31.05 to mean target of $68.07, Based on 23 analyst forecasts
Low
$33.33
Median
$66.30
High
$105.00

Price Target Revisions

1 Month
-1.77%
3 Months
-2.44%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for IMCR. The average price target is 68.07 USD. This implies a price increase of 119.22% is expected in the next year compared to the current price of 31.05.
The average price target has been revised downward by 2.44% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IMCR Current Analyst RatingIMCR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

IMCR Historical Analyst RatingsIMCR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
81.74%
IMCR was analyzed by 23 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about IMCR.
In the previous month the buy percentage consensus was at a similar level.
IMCR was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16JefferiesDowngrade Buy -> Hold
2026-02-26NeedhamMaintains Buy -> Buy
2026-02-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-10Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-10-31Wells FargoInitiate Overweight
2025-10-22HC Wainwright & Co.Reiterate Buy -> Buy
2025-06-02HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-08OppenheimerMaintains Outperform -> Outperform
2025-04-14JP MorganMaintains Overweight -> Overweight
2025-04-10NeedhamReiterate Buy -> Buy
2025-04-07MizuhoMaintains Neutral -> Neutral
2025-03-12NeedhamReiterate Buy -> Buy
2025-03-12HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-05HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-27NeedhamReiterate Buy -> Buy
2025-01-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-10NeedhamReiterate Buy -> Buy
2024-12-13Morgan StanleyDowngrade Overweight -> Equal-Weight
2024-11-11MizuhoDowngrade Outperform -> Neutral
2024-11-07NeedhamMaintains Buy -> Buy
2024-10-24UBSInitiate Sell
2024-10-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-11Morgan StanleyMaintains Overweight -> Overweight
2024-10-07GuggenheimDowngrade Buy -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
109.8M
Revenue Q2Q
16.96%
EPS Q2Q
-370.30%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
-0.28%
Revenue (3 Months)
-2.37%
EPS (1 Month)
-8.16%
EPS (3 Months)
-39.47%

Next Earnings Summary

IMCR is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.27 USD and the consensus revenue estimate is 109.80M USD.
The next earnings revenue estimate has been revised downward by 2.37% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IMCR revenue by date.IMCR revenue by date.
249.428M
73.58%		310.202M
24.37%		400.016M
28.95%		458.3M
14.57%		495.91M
8.21%		588.03M
18.58%		818.46M
39.19%		1.056B
29.02%		1.211B
14.68%		1.446B
19.41%		1.555B
7.54%
EBITDA
YoY % growth
IMCR ebitda by date.IMCR ebitda by date.
-55.559M
-58.88%		-66.257M
-19.26%		-42.087M
36.48%		-62.644M
-48.84%		-74.031M
-18.18%		-10.964M
85.19%		209.41M
2,009.98%		341.7M
63.17%		218.38M
-36.09%		378.83M
73.47%		568.96M
50.19%
EBIT
YoY % growth
IMCR ebit by date.IMCR ebit by date.
-59.649M
-45.13%		-70.461M
-18.13%		-45.353M
35.63%		-63.42M
-39.84%		-63.804M
-0.60%		-23.065M
63.85%		174.75M
857.65%		376.38M
115.38%		551.21M
46.45%		781.07M
41.70%		910.76M
16.60%
Operating Margin
IMCR operating margin by date.IMCR operating margin by date.
-23.91%-22.71%-11.34%-13.84%-12.87%-3.92%21.35%35.64%45.52%54.02%58.57%
EPS
YoY % growth
IMCR eps by date.IMCR eps by date.
-1.14
2.29%		-1.02
10.35%		-0.70
31.37%		-1.13
-61.51%		-1.39
-23.02%		0.52
137.42%		2.99
474.45%		6.30
110.86%		7.71
22.35%		10.66
38.18%		11.48
7.69%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.27
-370.30%		-0.27
-33.88%		-0.26-0.30
50.13%		-0.21
22.01%		-0.27
-1.59%		-0.28
-7.10%		-0.33
-10.23%
Revenue
Q2Q % growth		109.8M
16.96%		113.52M
15.88%		116.7M
12.54%		119.13M
14.02%		115.24M
4.95%		115.96M
2.15%		117.05M
0.30%		119.02M
-0.09%
EBITDA
Q2Q % growth		-20.323M
-635.80%		-17.918M
-35.32%		-16.896M
-256.54%		-17.522M
-6.68%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-16.836M
-365.60%		-15.674M
-5.37%		-15.693M
-118.84%		-17.631M
10.46%		-17.341M
-3.00%		-19.892M
-26.91%		-23.834M
-51.88%		-25.674M
-45.62%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IMCR Yearly Revenue VS EstimatesIMCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
IMCR Yearly EPS VS EstimatesIMCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
43.10%
EPS Next 5 Year
61.56%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
12.72%
Revenue Next 5 Year
20.80%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
29.62%
EBIT Next 5 Year
58.86%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IMMUNOCORE HOLDINGS PLC-ADR / IMCR Forecast FAQ

What is the price target for IMCR stock?

23 analysts have analysed IMCR and the average price target is 68.07 USD. This implies a price increase of 119.22% is expected in the next year compared to the current price of 31.05.

What is the next earnings date for IMCR stock?

IMMUNOCORE HOLDINGS PLC-ADR (IMCR) will report earnings on 2026-05-05, before the market open.

Can you provide the consensus estimates for IMMUNOCORE HOLDINGS PLC-ADR next earnings?

The consensus EPS estimate for the next earnings of IMMUNOCORE HOLDINGS PLC-ADR (IMCR) is -0.27 USD and the consensus revenue estimate is 109.80M USD.

Can you provide the expected long term growth rate for IMMUNOCORE HOLDINGS PLC-ADR stock?

The expected long term growth rate for IMMUNOCORE HOLDINGS PLC-ADR (IMCR) is 12.72%.